RARE•benzinga•
Ultragenyx Pharmaceutical's Earnings Outlook
Summary
Ultragenyx Pharmaceutical (NASDAQ:RARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Ultragenyx Pharmaceutical will report an earnings per share (EPS) of $-1.76.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga